Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fai l’upgrade a Pro+ | NYSE | Salute | Prodotti farmaceutici | 147,85 Mrd USD | 34,7x | -0,58 | 26,09 USD | -1,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 16,9% Rialzo | Fai l’upgrade a Pro+ | |
Fai l’upgrade a Pro+ | NYSE | Immobiliare | REIT residenziali e commerciali | 17,76 Mrd USD | 62x | 3,48 | 101,63 USD | 1,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 17,1% Rialzo | Fai l’upgrade a Pro+ | |
Fai l’upgrade a Pro+ | NYSE | Immobiliare | REIT residenziali e commerciali | 14,57 Mrd USD | 43,1x | 3,97 | 20,83 USD | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 20% Rialzo | Fai l’upgrade a Pro+ | |
Fai l’upgrade a Pro+ | NYSE | Prodotti di base | Sostanze chimiche | 25,10 Mrd USD | 11,8x | -2,05 | 77,36 USD | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 12,5% Rialzo | Fai l’upgrade a Pro+ | |
Fai l’upgrade a Pro+ | NYSE | Immobiliare | REIT residenziali e commerciali | 31,20 Mrd USD | 11x | 0,82 | 29,60 USD | 1,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 18,2% Rialzo | Fai l’upgrade a Pro+ |